| Literature DB >> 31013860 |
Louise Sealy1, Karen Zwi2, Gordon McDonald3, Aldo Saavedra4,5, Lisa Crawford6, Hasantha Gunasekera7,8.
Abstract
BACKGROUND: Patients who discharge against medical advice (DAMA) from hospital carry a significant risk of readmission and have increased rates of morbidity and mortality. We sought to identify the demographic and clinical characteristics of DAMA patients from a tertiary paediatric hospital.Entities:
Keywords: discharge; discharge against medical advice; discharge at own risk; self-discharge; treatment refusal
Mesh:
Year: 2019 PMID: 31013860 PMCID: PMC6518110 DOI: 10.3390/ijerph16081326
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Demographic characteristics (by number of patients).
| Demographic Characteristics | Total n (%) | DAMA n (DAMA %) | |
|---|---|---|---|
| Overall | 124,757 (100%) | 1730 (1.4%) | |
|
| |||
| Male | 72,304 (58%) | 989 (1.4%) | df = 1 |
| Female | 52,453 (42%) | 741 (1.4%) | |
|
| |||
| Neonate (0–28 days) | 5823 (4.7%) | 87 (1.5%) | |
| Infant (29 days–23 months) | 36,608 (29.3%) | 493 (1.3%) | df = 5 |
| Young Child (24 month–6 years) | 39,162 (31.4%) | 498 (1.3%) | |
| Child (7–12 years) | 28,559 (22.9%) | 386 (1.4%) | |
| Adolescent (13–17 years) | 14,451 (11.6%) | 260 (1.8%) | |
| Adult (18 years or more) | 154 (0.1%) | 6 (3.9%) | |
|
| |||
| Aboriginal | 3565 (2.9%) | 76 (2.1%) | |
| Not Aboriginal | 120,474 (96.6%) | 1647(1.4%) | df = 2 |
| Unknown | 718 (0.6%) | 7 (1.0%) | |
|
| |||
| Hospital site 1 | 76,693 (61.5%) | 1536 (2%) | df = 1 |
| Hospital site 2 | 48,064 (38.5%) | 194 (0.4%) | |
|
| |||
| Low 400–850 | 6350 (5.1%) | 121 (1.9%) | |
| Med 851–1000 | 49,492 (40%) | 775 (1.6%) | df = 2 |
| High 1001–1150 | 67,901 (54%) | 810 (1.2%) | |
| Unmatched (not incl. in test) | 1014 (0.8%) | 24 (2.4%) | |
|
| |||
| Major cities | 112,204 (90%) | 1531 (1.4%) | |
| Inner regional | 8885 (7.1 %) | 136 (1.5%) | df = 4 |
| Outer regional | 2388 (1.9%) | 34 (1.4%) | |
| Remote | 256 (0.2%) | 3 (1.2%) | |
| Very Remote | 101 (0.1%) | 2 (2.0%) | |
| Unmatched (not incl. in test) | 923 (0.7%) | 24 (2.6%) |
* Index of Relative Socioeconomic Disadvantage (IRSD) was used as a measure of socioeconomic status. This is a general socioeconomic index that summarises a range of information about social and economic conditions of people and households within the area. It includes only measures of relative disadvantage. A low index score indicates a relatively greater disadvantage.
Clinical characteristics (by number of admissions).
| Clinical Characteristics | Total n (%) | DAMA n (DAMA %) | |
|---|---|---|---|
| Total Admissions | 246,359 (100%) | 1817 (0.7%) | |
|
| |||
| Emergency | 111,707 (45.3%) | 969 (0.9%) | |
| Planned | 125,176 (50.8%) | 768 (0.6%) | df = 2 |
| Other | 9476 (3.8%) | 80 (0.8%) | |
|
| |||
| A,B—Infection | 10,590 (4.3%) | 77 (0.7%) | |
| C,D—Neoplasm/Blood/Immune | 24,753 (10.0%) | 158 (0.6%) | df = 17 |
| E—Endocrine/Nutritional/Metabolic | 8168 (3.3%) | 83 (1.0%) | |
| F—Mental, Behavioural | 2593 (1.1%) | 58 (2.2%) | |
| G—Nervous system | 14,118 (5.7%) | 80 (0.6%) | |
| H—Eye, Ear, Adnexa | 7520 (3.1%) | 61 (0.8%) | |
| I—Circulatory | 2646 (1.1%) | 20 (0.8%) | |
| J—Respiratory | 28,579 (11.6%) | 226 (0.8%) | |
| K—Digestive | 19,762 (8.0%) | 170 (0.9%) | |
| L—Skin | 7028 (2.9%) | 51 (0.7%) | |
| M—Musculoskeletal | 9531 (3.9%) | 74 (0.8%) | |
| N—Genitourinary | 9607 (3.9%) | 51 (0.5%) | |
| O—Pregnancy & Childbirth | 5 (0.002%) | 0 (0%) | |
| P—Perinatal | 2490 (1.0%) | 17 (0.7%) | |
| Q—Congenital & chromosomal | 22,478 (9.1%) | 133 (0.6%) | |
| R—Other symptoms | 21,093 (8.6%) | 216 (1.0%) | |
| S,T—Injury/poisoning | 31,718 (12.9%) | 225 (0.7%) | |
| Z—Other diagnosis | 21,684 (8.8%) | 92 (0.4%) | |
| Missing/Unmatched | 1996 (0.8%) | 25 (1.3%) | |
|
| |||
| No | 197,324 (80.1%) | 1429 (0.7%) | df = 1 |
| Yes | 49,035 (19.9%) | 388 (0.8%) |
Predictors of DAMA per admission (Bayesian multivariable logistic regression).
| Characteristic | OR | (95% CI) | ||
|---|---|---|---|---|
|
|
|
|
|
|
| Hospital 2 | 1.00 | |||
|
| A,B—Infection | 1.00 | ||
| C,D—Neoplasm, Blood, Immune | 1.18 | (0.85–1.56) | 0.47 | |
| E—Endocrine, Nutritional, Metabolic | 1.55 | (1.06–2.12) | 0.09 | |
|
|
|
|
| |
| G—Nervous system | 1.08 | (0.80–1.77) | 0.62 | |
| H—Eye, Ear, Adnexa | 1.35 | (0.98–2.02) | 0.20 | |
| I—Circulatory | 1.30 | (0.74–2.13) | 0.53 | |
| J—Respiratory | 1.15 | (0.86–1.44) | 0.52 | |
|
|
|
|
| |
| L—Skin | 1.18 | (0.79–1.62) | 0.54 | |
| M—Musculoskeletal | 1.23 | (0.84–1.64) | 0.49 | |
| N—Genitourinary | 0.93 | (0.61–1.26) | 0.70 | |
| P—Perinatal | 1.39 | (0.81–2.18) | 0.38 | |
| Q—Congenital, Chromosomal | 1.12 | (0.82–1.53) | 0.64 | |
| R—Other Symptoms | 1.45 | (1.10–1.90) | 0.07 | |
| S,T—Injury, Poisoning | 1.09 | (0.77–1.46) | 0.75 | |
| Z—Other | 0.80 | (0.55–1.13) | 0.45 | |
|
| Emergency | 1.00 | reference | |
|
|
|
|
|
|
|
| Not Aboriginal | 1.00 | reference | |
|
|
|
|
| |
|
| No Prev. DAMA | 1.00 | reference | |
|
|
|
|
| |
|
| Metropolitan | 1.00 | reference | |
| Inner Regional Australia | 1.00 | (0.84–1.20) | 0.85 | |
| Outer Regional Australia | 0.95 | (0.62–1.24) | 0.67 | |
| Remote Australia | 0.44 | (0.02–0.96) | 0.35 | |
| Very Remote Australia | 1.23 | (0.11–3.81) | 0.82 | |
|
| Social disadvantage (numeric) | 1.00 | (1.00 – 1.00) | 0.52 |
|
| Not Preventable | 1.00 | reference | |
|
| Preventable | 0.95 | (0.79–1.13) | 0.63 |
|
| Age (numeric) | 1.00 | (0.99–1.01) | 0.75 |
|
| Male | 1 | reference | |
| Female | 0.97 | (0.88–1.10) | 0.77 |